Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.
NCT00141089
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1026
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Constipation
Interventions
DRUG:
Tegaserod
Sponsor
Novartis